How The Body Stores And Releases Glucose
Photo: Patrick Gamelkoorn / Pexels
At any given moment, a healthy adult carries only a few grams of glucose freely dissolved in the bloodstream, roughly a teaspoon's worth, while the brain alone burns through somewhere on the order of 100 grams of glucose a day just to keep neurons firing. That gap between a tiny circulating supply and a large, constant demand is bridged by a hormonally controlled storage-and-release system built around two opposing pancreatic hormones, insulin and glucagon, and a liver that functions as the body's central glucose reservoir. This article walks through exactly how that system works, mechanism by mechanism, without straying into diet or diabetes management advice.
What "blood glucose" actually is, and why it has to stay narrow
Glucose is a simple sugar, a single six-carbon molecule, that serves as the primary fuel most human cells burn for cellular energy. It enters the bloodstream mainly from the digestion of dietary carbohydrates, but the body can also manufacture it internally, a fact that becomes important later in this article. The concentration of glucose circulating in the blood at any given time is what clinicians measure as "blood sugar," typically expressed in milligrams per deciliter (mg/dL) in the United States or millimoles per liter (mmol/L) elsewhere.
That concentration is kept within a surprisingly narrow band. In a person without a glucose-regulation disorder, fasting blood glucose is normally maintained in roughly the 70 to 100 mg/dL range, according to standard clinical laboratory reference intervals used across endocrinology and primary care. Even after a large meal, blood glucose in a healthy person typically does not climb dramatically or stay elevated for long, because the storage system described in this article activates almost immediately.
The reason the range has to stay narrow in both directions is that glucose is dangerous at the extremes. Too much circulating glucose, sustained over time, damages blood vessels and nerves, which is the basis of long-term diabetic complications. Too little circulating glucose, hypoglycemia, starves tissues that depend heavily on glucose, most critically the brain, and can impair consciousness within minutes. The body therefore treats blood glucose less like a simple fuel gauge and more like a life-support parameter that has to sit inside a tight operating window at essentially all times, whether a person just finished a meal or has not eaten in fourteen hours.
This is why the storage-and-release system is not a passive backup, something that only kicks in during emergencies. It is running continuously, second by second, adjusting the balance between glucose entering the blood and glucose leaving it for storage or use, the same way a thermostat is not just a device for extreme temperatures but something constantly making small corrections to hold a room at a set point.
Insulin: how the body stores excess glucose
After a carbohydrate-containing meal, glucose absorbed from the intestine raises blood glucose concentration. This rise is detected by specialized beta cells located in clusters of pancreatic tissue called the islets of Langerhans, and in response, those beta cells secrete insulin, a peptide hormone whose core job is to move glucose out of the blood and into storage or immediate use inside cells.
Insulin acts on cells in two main ways. First, it binds to insulin receptors on the surface of muscle and fat cells, triggering a signaling cascade that causes glucose transporter proteins called GLUT4 to move from internal storage vesicles to the cell's outer membrane. Once GLUT4 transporters are embedded in the membrane, glucose can flow into the cell down its concentration gradient, effectively opening a door that was previously shut. Without insulin's signal, GLUT4 stays parked inside the cell and very little glucose can get in, regardless of how much glucose is available in the surrounding blood.
Second, and central to the storage side of this system, insulin signals the liver to convert incoming glucose into glycogen, a large, branched polymer made of thousands of linked glucose molecules, through a metabolic pathway called glycogenesis. Glycogen is, functionally, the body's short-term glucose warehouse: a dense, compact storage form that can be rapidly broken back down into individual glucose molecules when needed, unlike glucose itself, which cannot be stored in large quantities in free form without drawing excess water into cells by osmosis.
The liver is not the only glycogen-storing organ. Skeletal muscle also stores substantial glycogen, and across the whole body muscle tissue typically holds a larger total glycogen mass than the liver does. But there is a critical functional difference between the two stores, covered in detail in the next section, that determines which organ's glycogen actually helps maintain blood glucose for the rest of the body.
Why liver glycogen, not muscle glycogen, keeps blood glucose stable
Both liver and muscle cells can build glycogen chains from glucose and both can break those chains back down when energy is needed, a process called glycogenolysis. The difference is what happens to the glucose molecule after it is released from the glycogen chain inside each type of cell.
When glycogen breaks down, the first product is not free glucose but glucose-1-phosphate, which is then converted to glucose-6-phosphate. Glucose-6-phosphate cannot cross the cell membrane; a phosphate group has to be removed first to produce free glucose that can exit the cell. The enzyme that removes that phosphate group is glucose-6-phosphatase, and the liver expresses it at high levels, along with the kidney and intestine to a lesser degree, according to NIH/NCBI biochemical reviews of glycogen metabolism. Skeletal muscle largely lacks this enzyme.
The practical consequence is significant. Liver cells can strip the phosphate off, release plain glucose into the bloodstream, and directly raise blood glucose for use by the brain, red blood cells, and every other tissue in the body. Muscle cells, lacking meaningful glucose-6-phosphatase activity, can only use the glucose-6-phosphate generated from their own glycogen internally, feeding it straight into the muscle cell's own energy-producing pathways. Muscle glycogen fuels muscle contraction; it essentially cannot be exported to raise blood glucose for other organs.
This is the reason clinical and physiological discussions of "glucose storage" focus so heavily on the liver specifically, even though total muscle glycogen mass is larger. The liver is the organ actually equipped to act as a shared, exportable reservoir; muscle glycogen is a private fuel tank that only serves the tissue that built it. A useful comparison is a household with a shared pantry in the kitchen and a personal snack drawer in each bedroom: everyone in the house can draw from the pantry, but a snack drawer in one bedroom does nothing to feed anyone sleeping down the hall.
How much glycogen does the liver actually hold?
Liver glycogen storage capacity is finite, generally described in physiology and biochemistry references as being on the order of 100 grams in an average adult liver, though the exact figure varies with body size, recent diet, and individual variation. Because the brain alone can use roughly 100 grams of glucose a day, liver glycogen represents a buffer measured in hours, not days, which is exactly why the next backup mechanism, described below, exists.
Glucagon: how the body triggers glucose release
As blood glucose falls between meals, overnight, or during exercise, a second set of pancreatic cells, the alpha cells, also located within the islets of Langerhans, detect the drop and respond by secreting glucagon, a hormone that functions as insulin's physiological opposite. Where insulin promotes storage, glucagon promotes release.
Glucagon's primary target is the liver. It binds to glucagon receptors on liver cell membranes and activates a signaling cascade, involving the second messenger cyclic AMP, that switches on the enzymes responsible for breaking glycogen down (glycogenolysis) while simultaneously switching off the enzymes responsible for building glycogen up (glycogenesis). The liver cell essentially flips from storage mode to release mode within minutes of the hormonal signal arriving.
Glucagon does not have a comparable direct effect on skeletal muscle glycogen breakdown in the way it does on the liver, largely because muscle cells have far fewer glucagon receptors than liver cells do. Muscle glycogen breakdown during exercise is instead driven mainly by local signals tied to muscle contraction itself and by epinephrine (adrenaline), not primarily by glucagon. This reinforces the earlier point: the liver-glucagon axis is specifically the system responsible for maintaining blood glucose for the whole body, while muscle glycogen serves the muscle in a more self-contained loop.
Insulin and glucagon are secreted by different cell populations within the same pancreatic islets and act in a push-pull relationship: rising blood glucose favors insulin secretion and suppresses glucagon, while falling blood glucose favors glucagon secretion and suppresses insulin. It is this reciprocal signaling, not either hormone acting alone, that keeps blood glucose oscillating within its narrow reference range rather than swinging widely after every meal or every gap between meals.
| Feature | Insulin | Glucagon |
|---|---|---|
| Source cell | Pancreatic beta cells | Pancreatic alpha cells |
| Trigger | Rising blood glucose (after eating) | Falling blood glucose (fasting, exercise) |
| Main target organs | Liver, skeletal muscle, adipose tissue | Liver (primarily) |
| Core action | Promotes glucose uptake into cells and glycogenesis | Promotes glycogenolysis and gluconeogenesis |
| Net effect on blood glucose | Lowers it | Raises it |
Insulin and glucagon are reciprocal signals from the same pancreatic islets, one driving storage, the other driving release, and together they hold blood glucose within its narrow reference range.
How quickly do these hormones act after a meal?
Insulin secretion begins rising within minutes of blood glucose starting to climb after a meal, and measurable effects on cellular glucose uptake follow shortly after, since GLUT4 transporter movement to the cell membrane is a fast, receptor-triggered process rather than one requiring new protein synthesis from scratch. Glucagon's release and its glycogenolysis-triggering effect on the liver operate on a similarly fast, minutes-to-tens-of-minutes timescale once blood glucose starts falling.
Gluconeogenesis: making new glucose once glycogen runs low
Liver glycogen is a finite reserve, and once it is substantially depleted, typically after roughly half a day to a full day of fasting depending on the individual, the liver shifts to a different, more metabolically demanding process called gluconeogenesis, literally "the creation of new glucose."
Gluconeogenesis builds glucose molecules from non-carbohydrate starting materials. The three main sources documented in metabolic physiology are amino acids released from the breakdown of body protein, lactate produced by tissues such as exercising muscle and red blood cells, and glycerol released when stored fat (triglycerides) is broken down. The liver, and to a lesser extent the kidneys, run these precursors through a series of enzymatic steps that essentially reverses much of the glycolysis pathway cells normally use to break glucose down, rebuilding a glucose molecule from smaller pieces.
This process is more energetically expensive than simply breaking down stored glycogen; it requires the liver to expend cellular energy to construct each glucose molecule rather than just release one that is already formed. Because of that cost, gluconeogenesis was historically framed in textbooks as a last-resort mechanism reserved for prolonged starvation. Fasting physiology research has since made clear that gluconeogenesis is active to a meaningful degree even during ordinary overnight fasting, contributing to blood glucose maintenance well before liver glycogen is fully exhausted, not just during extreme, multi-day fasting states.
Gluconeogenesis is also the reason glucagon's job description extends beyond "break down stored glycogen." Glucagon signaling in the liver also promotes gluconeogenic enzyme activity, meaning the same hormone that triggers the fast, short-term glycogen release also helps activate the slower, longer-term glucose-manufacturing pathway that takes over once glycogen reserves are running low.
What happens once fasting extends beyond a day or two?
As fasting continues beyond roughly 24 to 48 hours, gluconeogenesis increasingly relies on amino acids from protein breakdown to supply raw material, and simultaneously the liver begins converting fatty acids into ketone bodies. Ketone bodies are water-soluble molecules that, unlike most fatty acids, can cross the blood-brain barrier and be used directly by brain tissue for energy, a well-documented adaptation in starvation physiology research that reduces the brain's absolute glucose requirement and slows the rate of muscle protein breakdown that would otherwise be needed to keep gluconeogenesis supplied.
Why the brain's glucose dependence shapes the entire system
The intensity of this hormonal machinery, two dedicated hormones, a dedicated storage organ, and a backup synthesis pathway, exists largely because of one organ's fuel requirements: the brain. The adult human brain accounts for roughly 20% of the body's resting energy expenditure despite making up only about 2% of total body weight, a disproportion widely cited in brain energy metabolism research (Physiological Reviews, "Brain Glucose Metabolism: Integration of Energetics with Function," 2018).
Under everyday conditions, the brain relies overwhelmingly on glucose to meet that energy demand. Unlike skeletal muscle, which can switch relatively easily to burning fatty acids when glucose is scarce, brain tissue under short-term, non-fasted conditions cannot use fatty acids efficiently as a substitute fuel, because fatty acids do not cross the blood-brain barrier in meaningful quantities. That single biochemical restriction is a major reason the body maintains such an elaborate, redundant system, glycogen for fast release, gluconeogenesis for sustained release, to keep blood glucose from dropping too far, for too long, at any point in the day or night.
The consequences of failing to maintain that supply are immediate and well documented in clinical medicine. Sustained or severe hypoglycemia can impair concentration and coordination within minutes and, in more extreme or prolonged cases, can lead to loss of consciousness or seizure, which is precisely the outcome the insulin-glucagon-glycogen-gluconeogenesis system exists to prevent.
A useful analogy here is a data center's backup power design. Battery banks handle the first few minutes of a power outage instantly and automatically, buying time without any noticeable disruption, but they hold a limited charge. If the outage continues, diesel generators start up, a slower, more resource-intensive system, but one capable of running for a sustained period. Liver glycogen functions like the battery bank: immediate, automatic, and limited. Gluconeogenesis functions like the generator: slower to matter, more metabolically costly to run, but able to sustain output for far longer. Neither system alone would be sufficient; the body, like a well-designed data center, needs both a fast-acting reserve and a slower, self-sustaining backup working in sequence.
Where this regulatory system breaks down
Because insulin and glucagon act on the same underlying storage-and-release pathway, most disruptions to glucose regulation can be understood as a failure at one specific point in that pathway rather than a wholesale collapse of glucose metabolism.
In type 1 diabetes, the immune system destroys the pancreas's insulin-producing beta cells, so the "storage" signal is effectively missing altogether. Even if blood glucose rises sharply after a meal, without insulin, GLUT4 transporters largely stay parked inside muscle and fat cells and the liver does not receive the signal to store incoming glucose as glycogen. Blood glucose can climb to abnormal levels not because the body cannot handle glucose in principle, but because the specific hormonal key needed to unlock that handling is absent.
In type 2 diabetes, insulin is generally still produced, sometimes even in elevated amounts, but target cells respond to it poorly, a state called insulin resistance, meaning the storage signal is present but is not being received effectively. This is frequently compounded by impaired suppression of glucagon secretion, so the liver may continue releasing glucose, via glycogenolysis and gluconeogenesis, even when blood glucose is already elevated, a combination that research in endocrinology literature describes as a dual defect involving both insufficient glucose disposal and inappropriate ongoing glucose production.
Both conditions ultimately trace back to the same core system described throughout this article; they disrupt it at different points, one by removing the hormonal signal, the other by blunting the response to a signal that is still present alongside unchecked release. This article is limited to explaining that underlying mechanism and does not offer guidance on diagnosing, treating, or managing either condition, which requires individualized medical care.
Common misconceptions about glucose storage and release
A frequent misunderstanding is that eating sugar directly and immediately becomes usable "energy" in a simple, linear sense. In reality, glucose entering the bloodstream after a meal triggers a regulated storage response mediated by insulin, and a substantial share of that glucose is moved into glycogen storage rather than being burned immediately, which is a major reason blood glucose in a person with healthy insulin function typically returns close to baseline within roughly one to two hours after eating.
Another common error is assuming all glycogen in the body works interchangeably. As detailed earlier, liver glycogen can be exported into the bloodstream to help every organ in the body, while muscle glycogen, lacking meaningful glucose-6-phosphatase activity, is functionally locked inside the muscle cell that produced it. This distinction is why liver health specifically, rather than total-body glycogen mass, is central to maintaining blood glucose during a fast.
A third misconception treats gluconeogenesis as an exotic process that only matters in extreme starvation. Physiological research indicates it contributes to glucose supply during ordinary, everyday fasting intervals, such as the stretch between dinner and breakfast, once liver glycogen begins to run low, not solely during multi-day fasting or true starvation states.
A fourth misconception conflates insulin's role with simply "processing sugar" in a generic sense. Insulin's action is specific: it opens a transport pathway (via GLUT4) into certain cell types and separately signals the liver's glycogen-building machinery. Cells and tissues that do not depend on insulin-triggered GLUT4 movement, such as most brain cells, which primarily use insulin-independent glucose transporters, take up glucose through a largely separate mechanism, which is part of why the brain can continue drawing on circulating glucose even under conditions where insulin signaling elsewhere in the body is impaired.
FAQ
Q: How does insulin lower blood glucose after a meal?
Insulin, released by pancreatic beta cells when blood glucose rises, triggers GLUT4 glucose transporter proteins to move to the surface of muscle and fat cells, allowing glucose to enter, and separately signals the liver to convert excess glucose into glycogen through glycogenesis. Both actions pull glucose out of the bloodstream and into storage or immediate cellular use.
Q: Why can the liver release stored glucose into the blood but muscle cannot?
The liver expresses high levels of glucose-6-phosphatase, an enzyme that converts the intermediate product of glycogen breakdown into free glucose capable of crossing the cell membrane into the bloodstream. Skeletal muscle largely lacks this enzyme, so muscle glycogen can only be used internally by the muscle cell that stored it, not exported to raise blood glucose for other organs.
Q: What happens once the liver runs out of stored glycogen?
The liver shifts to gluconeogenesis, synthesizing new glucose from non-carbohydrate sources including amino acids, lactate, and glycerol. This pathway typically becomes an increasingly important glucose source after roughly 12 to 24 hours of fasting, once liver glycogen reserves are substantially depleted, though it contributes to some degree even during shorter, everyday fasting intervals.
Q: Why does the brain need such a steady glucose supply?
The brain accounts for roughly 20% of the body's resting energy expenditure despite being only about 2% of body weight, and under normal short-term conditions it relies heavily on glucose because fatty acids cannot cross the blood-brain barrier in meaningful amounts. That dependence is a major reason the body maintains a multi-layered hormonal system, insulin, glucagon, liver glycogen, and gluconeogenesis, to keep blood glucose within a narrow range at essentially all times.
Q: What is the difference between insulin and glucagon in one sentence?
Insulin, released when blood glucose rises, promotes glucose uptake into cells and glycogen storage in the liver, while glucagon, released when blood glucose falls, promotes the breakdown of that stored glycogen and the synthesis of new glucose to raise blood glucose back up.
The takeaway
Glucose storage and release is not a single mechanism but a layered system: insulin drives glucose into cells and into liver glycogen after meals, glucagon triggers that glycogen's breakdown and eventual gluconeogenesis during fasting, and the liver's unique glucose-6-phosphatase enzyme is what makes it, rather than muscle, the organ capable of exporting glucose to the rest of the body. The entire system is built around one constraint: the brain's heavy, relatively inflexible glucose dependence means blood glucose has to stay within a narrow range continuously, not just after eating. Type 1 and type 2 diabetes disrupt this balance at different points along the same pathway, which is precisely why they require different underlying treatment strategies, a distinction that only becomes clear once the storage-release mechanism itself is understood.
Read next:
Follow new articles
Add SciHub101 to your feed reader to see new science and technology stories.
About the Author
SciHub101 is an independent science and technology publication founded and edited by Buğra Sözeri, a software engineer and app developer based in Türkiye. AI tools assist with drafting and research. Source documentation in the existing archive is uneven, and articles are being reviewed and corrected. The Editorial Team byline identifies editorial responsibility; it does not certify specialist or independent human review. Where we compare products, anything built by our own team is labelled as such — see the editorial guidelines and About page for how corrections and disclosures work.
Related Articles
Sex Hormones Explained — Testosterone and Estrogen
How testosterone, estrogen, and progesterone shape the body, the menstrual cycle, puberty, and menopause — and the science of hormone therapy.
Insulin and Diabetes Explained: Biology, Types, Treatment
How insulin controls blood glucose, why type 1 and type 2 diabetes differ, and how treatment moved from animal extracts to pumps, drugs, and stem cells.
Type 2 Diabetes: The Biology Behind the Epidemic
Type 2 diabetes starts with insulin resistance and failing beta cells. See the biology, what remission trials show, and how treatments target each step.
The Biology of Obesity and Metabolic Syndrome
Obesity is a chronic disease shaped by hormones, brain, and environment. See how leptin, insulin resistance, and visceral fat drive metabolic syndrome.